ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Uterine rupture,Reproductive system and breast injuries,Injuries NEC,Inj&P,N
2,1,Uterine rupture,Reproductive system and breast injuries,Injuries NEC,Inj&P,N
3,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
4,1,Uterine rupture,Reproductive system and breast injuries,Injuries NEC,Inj&P,N
5,1,Uterine rupture,Reproductive system and breast injuries,Injuries NEC,Inj&P,N
6,1,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
7,1,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
8,1,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
9,1,Uterine rupture,Reproductive system and breast injuries,Injuries NEC,Inj&P,N
10,1,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
11,1,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
12,1,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
13,1,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
14,1,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
15,1,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
16,1,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
17,1,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
18,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
18,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
19,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
19,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
20,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
20,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
21,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
21,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
21,3,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
22,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
22,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
23,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
23,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
24,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
24,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
24,3,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
25,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
25,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
25,3,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
26,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
26,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
27,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
28,1,Uterine hypertonus,Maternal complications of labour NEC,Maternal complications of labour and delivery,Preg,N
29,1,Haemorrhage in pregnancy,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
29,2,Uterine hypertonus,Maternal complications of labour NEC,Maternal complications of labour and delivery,Preg,N
30,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
31,1,Uterine hypertonus,Maternal complications of labour NEC,Maternal complications of labour and delivery,Preg,N
32,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
33,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
34,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
35,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
36,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
36,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
36,3,Laryngeal oedema,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
36,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
37,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
38,1,Anaphylactoid syndrome of pregnancy,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
39,1,Uterine rupture,Reproductive system and breast injuries,Injuries NEC,Inj&P,N
40,1,Headache,Headaches NEC,Headaches,Nerv,N
40,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
41,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
41,2,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
42,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
42,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
43,1,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
44,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
44,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
45,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
45,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
46,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
46,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
47,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
48,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
48,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
48,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
49,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
49,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
50,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
51,1,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
52,1,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
53,1,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
54,1,Eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
54,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
55,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
55,2,Coma,Coma states,Neurological disorders NEC,Nerv,N
55,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
56,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
57,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
58,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
59,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
59,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
60,1,Amputation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
60,2,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
61,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
61,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
61,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
61,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
61,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
61,6,Vasodilatation,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
62,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
62,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
62,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
62,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
62,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
63,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
64,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
64,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
65,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
65,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
66,1,Water intoxication,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
67,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
68,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
69,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
69,2,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
70,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
71,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
72,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
73,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
73,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
73,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
74,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
74,2,Water intoxication,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
75,1,Uterine rupture,Reproductive system and breast injuries,Injuries NEC,Inj&P,N
76,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
76,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
76,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
76,4,Neonatal respiratory failure,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
76,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
77,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,Y
77,2,Neonatal asphyxia,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
78,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
78,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
79,1,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
80,1,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
81,1,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
82,1,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
83,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
83,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
83,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
83,4,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
83,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
84,1,Uterine rupture,Reproductive system and breast injuries,Injuries NEC,Inj&P,N
85,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
86,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
87,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
87,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
87,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
88,1,Water intoxication,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
89,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
89,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
90,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
90,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
91,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
91,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
91,3,Prolonged labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
92,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
92,2,Failed trial of labour,Failed labour,Maternal complications of labour and delivery,Preg,N
93,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
93,2,Prolonged labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
94,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
94,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
94,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
95,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
95,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
96,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
96,2,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
97,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
97,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
97,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
98,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
99,1,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
99,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
100,1,Headache,Headaches NEC,Headaches,Nerv,N
100,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
100,3,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
100,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
101,1,Headache,Headaches NEC,Headaches,Nerv,N
101,2,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
102,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
103,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
104,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
104,2,Water intoxication,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
105,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
105,2,Water intoxication,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
106,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
107,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
108,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
109,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
109,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
110,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
110,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
111,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
112,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
113,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
114,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
115,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
115,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
116,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
116,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
117,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
117,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
118,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
118,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
119,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
119,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
120,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
120,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
121,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
121,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
122,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
122,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
123,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
123,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
124,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
124,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
125,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
125,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
126,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
126,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
127,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
127,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
128,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
128,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
129,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
130,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
130,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
131,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
132,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
132,2,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
133,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
134,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
134,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
134,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
135,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
136,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
136,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
136,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
137,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
137,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
138,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
139,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
139,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
139,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
139,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
140,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
141,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
141,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
142,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
142,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
143,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
143,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
144,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
144,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
145,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
146,1,Gravitational oedema,Oedema NEC,General system disorders NEC,Genrl,N
146,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
147,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
147,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
148,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
148,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
149,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
150,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
151,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
152,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
152,2,Headache,Headaches NEC,Headaches,Nerv,N
152,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
152,4,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
153,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
153,2,Neonatal seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
153,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
154,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
154,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
155,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
156,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
156,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
156,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
157,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
158,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
159,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
160,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
161,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
162,1,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
163,1,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
164,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
164,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
164,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
164,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
165,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
165,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
165,3,Uterine disorder,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
166,1,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
166,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
167,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
168,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
168,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
169,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
169,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
170,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
170,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
171,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
171,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
171,3,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
172,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
173,1,Uterine rupture,Reproductive system and breast injuries,Injuries NEC,Inj&P,N
174,1,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
174,2,Tachycardia foetal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
175,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
175,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
176,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
176,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
177,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
177,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
178,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
178,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
179,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
179,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
180,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
180,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
181,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
181,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
182,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
182,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
183,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
183,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
184,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
184,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
185,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
185,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
185,3,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
186,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
186,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
187,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
187,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
187,3,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
188,1,Brain hypoxia,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
189,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
189,2,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
189,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
189,4,Hypovolaemic shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
190,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
190,2,Foetal heart rate disorder,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
190,3,Tachycardia foetal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
191,1,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
192,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
193,1,Migraine,Migraine headaches,Headaches,Nerv,N
193,2,Retinal artery occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
194,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
194,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
194,3,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
195,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
195,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
195,3,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
196,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
196,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
197,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
198,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
199,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
200,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
201,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
202,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
202,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
203,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
203,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
204,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
204,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
205,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
205,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
206,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
206,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
206,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
207,1,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
208,1,Foetal heart rate abnormal,Foetal and neonatal diagnostic procedures,Foetal and neonatal investigations,Inv,N
209,1,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
210,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
211,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
211,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
212,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
212,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
213,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
213,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
213,3,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
214,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
214,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
214,3,Poor peripheral circulation,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
214,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
214,5,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
214,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
215,1,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
216,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
217,1,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
218,1,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
219,1,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
220,1,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
221,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
222,1,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
223,1,Foetal heart rate abnormal,Foetal and neonatal diagnostic procedures,Foetal and neonatal investigations,Inv,N
224,1,Foetal heart rate deceleration abnormality,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
225,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
226,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
227,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
228,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
229,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
230,1,Uterine rupture,Reproductive system and breast injuries,Injuries NEC,Inj&P,N
231,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
232,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
233,1,Acute right ventricular failure,Right ventricular failures,Heart failures,Card,N
234,1,Atrial pressure increased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
234,2,Mean arterial pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
235,1,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
236,1,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
236,2,Haemangioma,Cardiovascular neoplasms benign,Miscellaneous and site unspecified neoplasms benign,Neopl,N
236,3,Neonatal respiratory distress,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
236,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
236,5,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
237,1,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
238,1,Uterine atony,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
239,1,Anaesthetic complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
239,2,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
239,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
239,4,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
239,5,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
240,1,Retinal disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
240,2,Visual field defect,Visual field disorders,Vision disorders,Eye,N
241,1,Sepsis neonatal,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
242,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
242,2,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
242,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
242,4,Uterine contractions during pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
243,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
243,2,Evacuation of retained products of conception,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
243,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
244,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
244,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
245,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
245,2,Vaginal haematoma,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
246,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
246,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
246,3,Vaginal haematoma,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
247,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
247,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
248,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
248,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
248,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
249,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
249,2,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,Y
250,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
250,2,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,Y
251,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
251,2,Bundle branch block left,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
251,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
251,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
251,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
251,6,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
251,7,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
251,8,Troponin I increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
252,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
253,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
254,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
254,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
254,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
254,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
254,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
255,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
256,1,Bradycardia foetal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
256,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
257,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
257,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
257,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
257,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
257,5,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
257,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
258,1,Foetal heart rate decreased,Foetal and neonatal diagnostic procedures,Foetal and neonatal investigations,Inv,N
259,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
259,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
259,3,Dilatation ventricular,Myocardial disorders NEC,Myocardial disorders,Card,N
259,4,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
259,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
260,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
260,2,Vasospasm,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
261,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
261,2,Hypopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
261,3,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
261,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
261,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
261,6,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
262,1,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
262,2,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
262,3,Vasoconstriction,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
262,4,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
263,1,Base excess,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
263,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
263,3,Hypotonia neonatal,Muscle tone abnormalities,Muscle disorders,Musc,N
263,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
263,5,Opisthotonus,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
263,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
263,7,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
263,8,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
264,1,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
265,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
265,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
265,3,Muscle necrosis,Myopathies,Muscle disorders,Musc,N
265,4,Pyometra,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
265,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
265,6,Uterine inversion,High risk pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
266,1,Apgar score low,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
266,2,Cerebral palsy,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
266,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
266,4,Foetal heart rate disorder,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
267,1,Maternal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
267,2,Uterine hypertonus,Maternal complications of labour NEC,Maternal complications of labour and delivery,Preg,N
268,1,Uterine rupture,Reproductive system and breast injuries,Injuries NEC,Inj&P,N
269,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
269,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
269,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
269,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
269,5,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
270,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
270,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
270,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
270,4,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
271,1,Abdominal hernia,Abdominal hernias NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
271,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
271,3,Cardiac failure,Heart failures NEC,Heart failures,Card,N
271,4,Eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
271,5,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
271,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
271,7,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
271,8,Peripartum cardiomyopathy,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
271,9,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
271,10,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
271,11,Wound dehiscence,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
272,1,Complex regional pain syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
272,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
272,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
273,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
273,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
273,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
274,1,Anaphylactoid syndrome of pregnancy,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
274,2,Brain death,Death and sudden death,Fatal outcomes,Genrl,Y
274,3,Cerebral artery embolism,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
274,4,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
274,5,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
274,6,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
274,7,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
274,8,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
274,9,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
274,10,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
275,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
275,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
275,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
275,4,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
275,5,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
275,6,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
275,7,Pneumonia streptococcal,Streptococcal infections,Bacterial infectious disorders,Infec,Y
275,8,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
275,9,Streptococcal sepsis,Streptococcal infections,Bacterial infectious disorders,Infec,N
276,1,Anhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
276,2,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
276,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
276,4,Horner's syndrome,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
276,5,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
276,6,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
276,7,Prolonged pregnancy,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
277,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
277,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
277,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
278,1,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
278,2,Uterine atony,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
279,1,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
279,2,Palatal oedema,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
280,1,Dextrocardia,Cardiac malpositions congenital,Cardiac and vascular disorders congenital,Cong,N
280,2,Foetal alcohol syndrome,Chemically-induced congenital syndromes,Congenital and hereditary disorders NEC,Cong,N
280,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
280,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
280,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
281,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
281,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
281,3,Nipple pain,Breast signs and symptoms,Breast disorders,Repro,N
281,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
281,5,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
281,6,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
282,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
282,2,Chest expansion decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
282,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
282,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
282,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
282,6,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
282,7,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
282,8,Postmature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
282,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
282,10,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
282,11,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
283,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
283,2,Chest expansion decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
283,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
283,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
283,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
283,6,Maternal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
283,7,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
283,8,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
283,9,PCO2 decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
283,10,PO2 decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
283,11,Prolonged pregnancy,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
283,12,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
283,13,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
283,14,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
283,15,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
284,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
284,2,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
284,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
284,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
284,5,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
284,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
285,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
285,2,Bundle branch block right,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
285,3,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
285,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
285,5,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
286,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
286,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
287,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
287,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
287,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
287,4,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
288,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
288,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
288,3,Pneumomediastinum,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
289,1,Cerebral palsy,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
289,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
290,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
291,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
292,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
293,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
294,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
295,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
295,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
295,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
295,4,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
295,5,Foetal hypokinesia,Foetal complications NEC,Foetal complications,Preg,N
295,6,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
296,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
296,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
296,3,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
296,4,Cervix enlargement,Cervix disorders NEC,Cervix disorders (excl infections and inflammations),Repro,N
296,5,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
296,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
296,7,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
296,8,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
296,9,Foetal hypokinesia,Foetal complications NEC,Foetal complications,Preg,N
296,10,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
296,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
296,12,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
296,13,Neutrophilia,Leukocytoses NEC,White blood cell disorders,Blood,N
296,14,Oligohydramnios,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
296,15,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
296,16,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
296,17,Premature rupture of membranes,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
296,18,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
296,19,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
296,20,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
296,21,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
296,22,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
297,1,Blood pressure systolic decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
297,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
297,3,Horner's syndrome,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
298,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
298,2,Horner's syndrome,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
299,1,Blood pressure systolic decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
299,2,Enophthalmos,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
299,3,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
299,4,Horner's syndrome,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
299,5,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
299,6,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
299,7,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
300,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
300,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
301,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
301,2,Foetal heart rate deceleration abnormality,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
301,3,Foetal heart rate decreased,Foetal and neonatal diagnostic procedures,Foetal and neonatal investigations,Inv,N
302,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
302,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
302,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
303,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
303,2,Horner's syndrome,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
303,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
304,1,Astigmatism,Refractive and accommodative disorders,Vision disorders,Eye,N
304,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
304,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
304,4,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
304,5,Retinal artery occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
304,6,Retinal disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
304,7,Retinal migraine,Migraine headaches,Headaches,Nerv,N
304,8,Retinal oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
304,9,Retinal pallor,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
304,10,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
304,11,Visual field defect,Visual field disorders,Vision disorders,Eye,N
304,12,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
305,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
306,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
307,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
308,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
309,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
310,1,Cerebral palsy,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
310,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
311,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
311,2,Uterine hypertonus,Maternal complications of labour NEC,Maternal complications of labour and delivery,Preg,N
312,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
312,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
312,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
313,1,Bradycardia foetal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
313,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
314,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
314,2,Rash neonatal,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
314,3,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
315,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
315,2,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
315,3,Uterine haemorrhage,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
315,4,Uterine inversion,High risk pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
316,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
316,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
316,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
316,4,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
316,5,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
317,1,Pneumomediastinum,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
317,2,Subcutaneous emphysema,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
318,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
319,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
320,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
321,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
322,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
322,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
322,3,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
322,4,Headache,Headaches NEC,Headaches,Nerv,N
322,5,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
322,6,Maternal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
322,7,Reversible cerebral vasoconstriction syndrome,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
323,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
323,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
323,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
324,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
324,2,Maternal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
324,3,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
325,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
325,2,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
326,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
326,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
327,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
327,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
328,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
328,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
329,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
330,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
330,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
330,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
330,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
330,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
330,6,Uterine rupture,Reproductive system and breast injuries,Injuries NEC,Inj&P,N
330,7,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
330,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
331,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
331,2,Uterine rupture,Reproductive system and breast injuries,Injuries NEC,Inj&P,N
332,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
332,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
333,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
334,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
334,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
335,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
335,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
335,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
335,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
336,1,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
337,1,Maternal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
337,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
337,3,Uterine atony,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
338,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
338,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
338,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
338,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
339,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
340,1,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
340,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
341,1,Foetal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
341,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
342,1,Apgar score low,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
342,2,Floppy infant,Muscle tone abnormalities,Muscle disorders,Musc,N
342,3,Foetal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
342,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
343,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
343,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
344,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
344,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
344,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
345,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
345,2,Hyponatraemic seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
346,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
346,2,Eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
346,3,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
346,4,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
346,5,Hyponatraemic seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
346,6,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
347,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
347,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
347,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
347,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
347,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
348,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
349,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
349,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
350,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
350,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
351,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
351,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
352,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
352,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
352,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
352,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
352,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
352,6,Spinal cord injury,Spinal cord injuries NEC,Injuries NEC,Inj&P,N
353,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
353,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
354,1,Maternal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
354,2,Palatal oedema,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
354,3,Palatal swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
354,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
355,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
355,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
355,3,Spinal cord injury,Spinal cord injuries NEC,Injuries NEC,Inj&P,N
356,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
356,2,Palatal oedema,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
357,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
357,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
357,3,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
357,4,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
357,5,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
357,6,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
357,7,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
357,8,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
357,9,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
357,10,Loss of control of legs,Gait disturbances,General system disorders NEC,Genrl,N
357,11,Muscle fatigue,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
357,12,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
357,13,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
357,14,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
357,15,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
357,16,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
357,17,Slow speech,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
357,18,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
357,19,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
357,20,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
358,1,Apnoeic attack,Breathing abnormalities,Respiratory disorders NEC,Resp,N
358,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
358,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
359,1,Administration site wound,Administration site reactions NEC,Administration site reactions,Genrl,N
359,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
359,3,Maternal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
359,4,Wound necrosis,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
360,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
361,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
361,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
361,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
361,4,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
361,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
362,1,Bradycardia foetal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
362,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
363,1,Foetal hypokinesia,Foetal complications NEC,Foetal complications,Preg,N
363,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
364,1,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
364,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
364,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
364,4,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
365,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
366,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
366,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
367,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
367,2,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,Y
367,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
368,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
369,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
369,2,Maternal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
370,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
370,2,Maternal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
371,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
371,2,Maternal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
371,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
371,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
372,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
372,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
372,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
372,4,Fear of death,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
372,5,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
372,6,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
373,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
373,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
373,3,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
373,4,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
374,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
374,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
375,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
376,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
376,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
376,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
376,4,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
376,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
377,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
378,1,Bruxism,Stereotypies and automatisms,Changes in physical activity,Psych,N
378,2,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
378,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
378,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
378,5,Uterine hypertonus,Maternal complications of labour NEC,Maternal complications of labour and delivery,Preg,N
379,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
379,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
379,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
379,4,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
380,1,Abnormal labour affecting foetus,Foetal conditions due to maternal conditions,Foetal complications,Preg,N
380,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
380,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
380,4,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
381,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
382,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
382,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
382,3,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
